298 related articles for article (PubMed ID: 25541719)
1. Mining CK2 in cancer.
Ortega CE; Seidner Y; Dominguez I
PLoS One; 2014; 9(12):e115609. PubMed ID: 25541719
[TBL] [Abstract][Full Text] [Related]
2. Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction.
Deshiere A; Duchemin-Pelletier E; Spreux E; Ciais D; Combes F; Vandenbrouck Y; Couté Y; Mikaelian I; Giusiano S; Charpin C; Cochet C; Filhol O
Oncogene; 2013 Mar; 32(11):1373-83. PubMed ID: 22562247
[TBL] [Abstract][Full Text] [Related]
3. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
[TBL] [Abstract][Full Text] [Related]
4. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
7. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
8. Cancer-type dependent expression of CK2 transcripts.
Chua MMJ; Lee M; Dominguez I
PLoS One; 2017; 12(12):e0188854. PubMed ID: 29206231
[TBL] [Abstract][Full Text] [Related]
9. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms.
Vilk G; Saulnier RB; St Pierre R; Litchfield DW
J Biol Chem; 1999 May; 274(20):14406-14. PubMed ID: 10318865
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer.
Lin KY; Tai C; Hsu JC; Li CF; Fang CL; Lai HC; Hseu YC; Lin YF; Uen YH
PLoS One; 2011 Feb; 6(2):e17193. PubMed ID: 21359197
[TBL] [Abstract][Full Text] [Related]
11. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
[TBL] [Abstract][Full Text] [Related]
12. Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro.
Williams MD; Nguyen T; Carriere PP; Tilghman SL; Williams C
Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010036. PubMed ID: 26703694
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma.
Rabjerg M; Guerra B; Oliván-Viguera A; Mikkelsen ML; Köhler R; Issinger OG; Marcussen N
Oncotarget; 2017 Jan; 8(1):1613-1627. PubMed ID: 27906674
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.
Turowec JP; Vilk G; Gabriel M; Litchfield DW
Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180
[TBL] [Abstract][Full Text] [Related]
16. Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies.
Chen JM; Gao C; Shi Q; Shan B; Lei YJ; Dong CF; An R; Wang GR; Zhang BY; Han J; Dong XP
Arch Virol; 2008; 153(6):1013-20. PubMed ID: 18404245
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.
Filhol O; Giacosa S; Wallez Y; Cochet C
Cell Mol Life Sci; 2015 Sep; 72(17):3305-22. PubMed ID: 25990538
[TBL] [Abstract][Full Text] [Related]
18. Targeting CK2-driven non-oncogene addiction in B-cell tumors.
Mandato E; Manni S; Zaffino F; Semenzato G; Piazza F
Oncogene; 2016 Nov; 35(47):6045-6052. PubMed ID: 27041560
[TBL] [Abstract][Full Text] [Related]
19. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.
Lou DY; Dominguez I; Toselli P; Landesman-Bollag E; O'Brien C; Seldin DC
Mol Cell Biol; 2008 Jan; 28(1):131-9. PubMed ID: 17954558
[TBL] [Abstract][Full Text] [Related]
20. Casein Kinase II: an attractive target for anti-cancer drug design.
Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
